Ep#020: Ultrapure DNA as a Novel Therapeutic Class with Dr. Cosimo Ducani

Personalized Medicine Podcast

In Episode 3 of Season 2 of the Personalized Medicine Podcast, our new host, Aradhana Chopra, sat down with Dr. Cosimo Ducani. Cosimo is the founder and CEO of Moligo Technologies, a Biotech start-up from Sweden that aims at providing alternative and improved enzymatic nucleic acid synthesis methods at the industrial scale. Cosimo talks about the increasing demand and need for long and ultra-pure DNA strands in diagnostics and therapeutics and explains oportunities and challenges young biotech start-ups are facing on their journey to success.
Together with Cosimo we talk about:
◦ What inspired Cosimo to start his own company
◦ Key focus areas of Moligo Technologies
◦ How can Moligo Technologies contribute towards personalized medicine and the development of nucleic acid-based vaccines
◦ Professor privilege and role of start-up incubators in early stage biotech ventures
◦ Positives of a lab & of a start-up setup
◦ Advice that Cosimo the CEO would give to Cosimo the scientist and vice-versa
◦ Cosimo’s tips to budding entrepreneurs
◦ Future of DNA-based therapeutics
Get in touch with Cosimo:
◦ Linkedin: Cosimo Ducani, Moligo Technologies
◦ Twitter: @CosimoDucani, @moligotech
◦ Web: https://www.moligotechnologies.com/
Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com